Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy

Sudeep Pushpakom, Munir Pirmohamed, Ruwanthi Kolamunnage‐Dona et al.|BMJ Open|2015

Cited by 29